Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 7/24/18 (What's New)

Summary

  • SVR is defined as undetectable HCV RNA 24 weeks following treatment end
    • For patients treated with PI-containing regimens, SVR is specifically defined as HCV RNA < 25 IU/mL at Week 24 posttreatment
    • SVR at 12 weeks after completion of treatment has been adopted by drug approval bodies as a surrogate for SVR24

Action required

Keywords: Hepatitis C-Treatment

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.